DAFTAR PUSTAKA

1. Terry TL. Extreme prematurity and fibroplastic overgrowth of persistentvascular

sheath behind each crystalline lens I. Preliminary report. Am
JOphthalmol. 1942;25:203-204.

2. Campbell K. Intensive oxygen therapy as a possible cause for retrolental fibroplasia.

A clinical approach. Med J Austr. 1951;2:48-50.

3. Alfian N. Faktor-faktor risiko untuk terjadinya retinopati pada prematuritas. Sari

Pediatri. 2001;3(3):152-156.

4. Tejiro B. Retinopathy of prematurity. Arch soc esp oftalmol. 2006; 81:129-130.

5. Padmani K, Jyotsna M, Angell L and Wilfried K. Retinopathy of prematurity and risk

factors: a prospective cohort study. BMC Pediatrics. 2005; 5(18):1-8.

6. Subramanian KNS, Rosenkrantz T. Retinopathy of Prematurity. Medscape, 2015.

7. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity,

1989-1997. Pediatrics. 1999;104(3):e26.
8. STOP-ROP. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of
Prematurity, a randomized, controlled trial. I: primary outcomes. Pediatrics.
2000;105(2):295-310.
9. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of
prematurity. Paediatr Perinat Epidemiol. 2004;18(2):130-4.
10. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of
prematurity among very low birth weight infants in Singapore. Ann Acad Med
Singapore. 2005;34(2):169-78.
11. Gilbert C, Fielder A, Gordillo L. Characteristics of infants with severe retinopathy of
prematurity in countries with low, moderate, and high levels of development:
implications for screening programs. Pediatrics. 2005;115(5):e518-25.
12. Repka MX, Summers CG, Palmer EA. The incidence of ophthalmologic interventions
in children with birth weights less than 1251 grams. Results through 5 1/2 years.
Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology.
1998;105(9):1621-7.
13. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of
Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10
years. Arch Ophthalmol. 2001;119(8):1110-8.
14. Tadesse M, Dhanireddy R, Mittal M, Higgins RD. Race, Candida sepsis, and
retinopathy of prematurity. Biol Neonate. 2002;81(2):86-90.
15. Bizzarro MJ, Hussain N, Jonsson B. Genetic susceptibility to retinopathy of
prematurity. Pediatrics. 2006;118(5):1858-63.
16. Lundgren P, Stoltz Sjostrom E, Domellof M. WINROP identifies severe retinopathy
of prematurity at an early stage in a nation-based cohort of extremely preterm
infants. PLoS One. 2013;12.8(9):e73256.

17. Anuk Ince D, Glcan H, Hanta D, Ecevit A, Akkoyun I, Kurt A, et al. Poor postnatal
weight gain predicts stage 3+ retinopathy of prematurity in very low birth weight
infants. Turk J Pediatr. 2013;55(3):304-8.

18. Hellstrom A, Hard AL, Engstrom E. Early weight gain predicts retinopathy in preterm
infants: new, simple, efficient approach to screening. Pediatrics. 2009;123(4):e638-
45.
19. International Committee for the Classification of Retinopathy of Prematurity. The
International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol.
2005;123(7):991-9.
20. Subhani M, Combs A, Weber P. Screening guidelines for retinopathy of prematurity:
the need for revision in extremely low birth weight infants. Pediatrics.
2001;107(4):656-9.
21. Mintz-Hittner HA, Kuffel RR Jr. Intravitreal injection of bevacizumab (avastin) for
treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina.
2008;28(6):831-8.
22. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10(2):133-40.
23. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, et al.
Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological
retinal angiogenesis. Nat Med. 2007;13(7):868-73.
24. Mantagos IS, Vanderveen DK, Smith LE. Emerging treatments for retinopathy of
prematurity. Semin Ophthalmol. 2009;24(2):82-6.
25. Stoltz Sjostrom E, Lundgren P, Ohlund I. Low energy intake during the first 4 weeks
of life increases the risk for severe retinopathy of prematurity in extremely preterm
infants. Arch Dis Child Fetal Neonatal Ed. 2015 Feb 12.
26. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser
photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-
year outcome. Am J Ophthalmol. 2001;132(1):76-80.
27. Nicoara SD, Cristian C, Irimescu I, Stefanut AC, Zaharie G. Diode Laser
Photocoagulation for Retinopathy of Prematurity: Outcomes After 7 Years of
Treatment. J Pediatr Ophthalmol Strabismus. 2013;19:1-7.
28. Anonim. Retinopathy of prematurity. American Academy of Ophtalmology. 2013.
29. Lukitasari A. Retinopati pada prematuritas. JKS 2012;2:118-121.
30. Dewi R, Tuhusula R, Rohsiswatmo R. Skrining retinophaty of prematurity di Rumah
Sakit dengan fasilitas terbatas. Sari Pediatri. 2012;14(3):185-90.